ANN ARBOR - NanoBio Corporation Wednesday announced a licensing agreement with the University of Michigan that provides NanoBio with rights to an antigen that has been shown to prevent urinary tract infections following intranasal vaccination. Through the agreement, NanoBio gains access to an antigen that University of Michigan researchers have shown can prevent recurring UTIs
WARREN - As we move ahead into the New Year, escalating health care costs continue to remain an issue of great concern for many organizations. Rising health care costs are inevitable as the total health benefit cost per employee has risen by approximately 6 percent annually for the past five years. And as the need
DETROIT - What will the Michigan innovation, life sciences, clean energy, transportation and information technology landscape look like 20 years from now? Will the area have emerged as an even bigger player in university and corporate research, or a major factor at all in areas like venture financing and entrepreneurial activity - and, if so,
DETROIT ? Human tissue bank Asterand and its subsidiary BioSeek announced that the United States Patent Office has issued a patent to cover key methods and applications of the company's BioMAP Systems technology. Patent 7,908,089 relates to BioMAP and its use for the classification of clinical patient tissue specimens according to the physiological status of
GRAND RAPIDS - Gentel Biosciences and Van Andel Research Institute announced Friday they have been granted U.S. Patent 7,838,634 for a new screening tool that could will help provide early detection of certain types of cancers. The patent provides for a new method to profile changes in the glycosylation of proteins captured on the surface
DETROIT - The Detroit Medical Center Cardiovascular Institute is the first healthcare provider in Michigan to offer a new breakthrough technology designed to correct atrial fibrillation (irregular heartbeat) in patients who struggle with this potentially life-threatening heart disorder. The new FDA-approved, state-of-the-art technology ? known formally as the "Arctic Front Cardiac CryoAblation Catheter system" ?
KALAMAZOO - NephRx Corporation Tuesday announced it was issued a U.S. patent for its peptide NX002 currently in preclinical development for the treatment of oral mucositis - a debilitating and often dose-limiting condition that affects more than 400,000 cancer patients who receive chemotherapy or radiation therapy in the United States each year. Current treatment options
GRAND RAPIDS - The Michigan chapter of Crohn's & Colitis Foundation of America will present its Take Steps Grand Rapids Walk fundraiser on May 7 at Grand Valley State University's Allendale campus. The event begins at 5 p.m. with registration/check-in, the walk starts at 6 p.m.. Take Steps Grand Rapids will feature a Kid?s Corral,
GRAND RAPIDS - In a recently-published study mapping the structure and function of the so-called orphan nuclear receptor TR4, Van Andel Research Institute investigators suggest that Vitamin A may play a more direct role than was previously known in certain physiological functions including sperm cell formation and the development of the central nervous system. Scientists
ANN ARBOR - Jeff DeGraff, the "Dean of Innovation," will keynote the MichBio Annual Meeting & Showcase April 18 when he talks about how he helped spur Domino's meteoric growth during the 1980s from a regional success story to an international franchise phenomenon. The MichBio Annual Meeting is scheduled for April 18 at the Inn